Welcome to Dwaey, specifically on Saxagliptin page.
This medicine contains important and useful components, as it consists of
Saxagliptin is available in the market in concentration.
Saxagliptin
Before starting treatment with saxagliptin, it is important for patients to consult their healthcare provider, as there are several precautions to consider:
- Pancreatitis: Saxagliptin has been associated with an increased risk of pancreatitis (inflammation of the pancreas). Patients with a history of pancreatitis or gallstones should be monitored closely. If symptoms such as severe abdominal pain occur, patients should seek immediate medical attention.
- Renal function: Saxagliptin is excreted primarily through the kidneys, so patients with renal impairment may require dosage adjustments. Monitoring kidney function is important for those with mild to moderate renal disease.
- Hypoglycemia: Saxagliptin, when used in combination with other diabetes medications like insulin or sulfonylureas, may increase the risk of low blood sugar (hypoglycemia). Regular blood sugar monitoring is advised to avoid hypoglycemia.
- Heart failure: The use of saxagliptin should be approached cautiously in patients with heart failure, particularly those with a history of cardiovascular disease. Saxagliptin has been associated with a slight increase in hospitalization for heart failure, although the overall risk is low.
- Pregnancy and breastfeeding: Saxagliptin is categorized as a pregnancy category C medication, which means its safety in pregnancy has not been well established. It should only be used during pregnancy if the benefits outweigh the risks. It is unknown whether saxagliptin passes into breast milk, so breastfeeding mothers should consult their healthcare provider before use.
- Allergic reactions: Severe allergic reactions such as angioedema (swelling beneath the skin) and anaphylaxis may occur. If signs of an allergic reaction (e.g., swelling, rash, or difficulty breathing) occur, patients should seek medical help immediately.
Saxagliptin is a medication used in the management of type 2 diabetes mellitus. It works by regulating blood sugar levels through the following:
- Type 2 Diabetes Mellitus: Saxagliptin is used to improve blood sugar control in adults with type 2 diabetes, particularly when used alongside diet and exercise. It is part of a class of drugs known as DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors).
- Combination therapy: Saxagliptin is often prescribed as an adjunct therapy in combination with other anti-diabetic drugs like metformin, sulfonylureas, or insulin to help further control blood glucose levels.
- Hyperglycemia management: By increasing the levels of incretin hormones, saxagliptin improves insulin secretion in response to meals and suppresses glucagon release, which helps lower blood sugar levels after meals.
Saxagliptin helps to achieve better glycemic control and reduce the risk of diabetes-related complications in patients with type 2 diabetes.
Saxagliptin should not be used in certain patients or situations:
- Hypersensitivity: Saxagliptin is contraindicated in patients who have a known hypersensitivity or allergic reaction to the drug or any of its components.
- Type 1 diabetes or diabetic ketoacidosis: Saxagliptin is not effective for the treatment of type 1 diabetes or diabetic ketoacidosis (a complication of diabetes characterized by high blood sugar and ketone buildup).
- Severe renal impairment: Saxagliptin is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73m²), as the drug is predominantly eliminated by the kidneys, and it may accumulate in the body in these patients.
- History of pancreatitis: Given the increased risk of pancreatitis associated with saxagliptin, patients with a history of pancreatitis should not use this medication.
- Pregnancy and breastfeeding: Saxagliptin should be avoided during pregnancy unless clearly necessary and under the advice of a healthcare provider. The safety of saxagliptin during breastfeeding has not been established.
While saxagliptin is generally well tolerated, it may cause side effects in some individuals:
- Common side effects:
- Upper respiratory tract infections (e.g., sore throat, sinusitis)
- Headache
- Nasopharyngitis (inflammation of the nose and throat)
- Mild gastrointestinal issues, such as nausea or diarrhea
- Serious side effects:
- Pancreatitis: There have been reports of acute pancreatitis in patients taking saxagliptin. Symptoms include severe abdominal pain, nausea, vomiting, and fever. If these symptoms occur, patients should discontinue the medication and seek immediate medical attention.
- Hypoglycemia: When combined with other medications that lower blood sugar, such as insulin or sulfonylureas, saxagliptin can increase the risk of hypoglycemia. Symptoms include shakiness, sweating, dizziness, and confusion.
- Heart failure: Some studies have shown that saxagliptin may slightly increase the risk of hospitalization for heart failure in patients with existing heart disease. Symptoms of heart failure include shortness of breath, swelling in the legs, and fatigue.
- Allergic reactions: Severe allergic reactions such as angioedema (swelling of the face, lips, tongue, or throat) or rash may occur. These require immediate medical attention.
- Kidney problems: Saxagliptin can affect kidney function, particularly in patients with pre-existing renal conditions, and should be used cautiously in those patients.
If any of these serious side effects occur, it is essential to contact a healthcare provider immediately.
2
Saxagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that works by increasing the levels of incretin hormones in the body. Incretins are hormones that are released in response to meals and help regulate blood sugar. Specifically, saxagliptin works by inhibiting the DPP-4 enzyme, which is responsible for breaking down incretin hormones like GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory peptide).
By inhibiting DPP-4, saxagliptin increases the levels of these hormones, which leads to several beneficial effects:
- Increased insulin secretion: Incretins stimulate the pancreas to release more insulin after meals, helping to lower blood sugar levels.
- Reduced glucagon release: Incretins inhibit the secretion of glucagon, a hormone that signals the liver to produce glucose. Lower levels of glucagon help reduce the amount of glucose released by the liver.
- Improved glycemic control: The combination of increased insulin secretion and decreased glucagon release helps to reduce overall blood glucose levels in patients with type 2 diabetes.
Saxagliptin helps improve postprandial (after meal) blood glucose levels and overall glycemic control.
Saxagliptin can interact with several medications, potentially affecting its efficacy or leading to side effects:
- Other anti-diabetic drugs: When used in combination with other diabetes medications like insulin or sulfonylureas, saxagliptin may increase the risk of hypoglycemia (low blood sugar). It may require dose adjustments of these medications.
- CYP3A4 inhibitors: Saxagliptin is metabolized by the liver enzyme CYP3A4. Strong inhibitors of CYP3A4 (e.g., ketoconazole, itraconazole, ritonavir) may increase the blood levels of saxagliptin, potentially leading to side effects. Dosage adjustments may be required.
- CYP3A4 inducers: Drugs that induce CYP3A4 activity (e.g., rifampin, phenytoin) may decrease saxagliptin’s effectiveness by reducing its plasma concentration.
- Renal medications: Diuretics, ACE inhibitors, or other medications affecting renal function may require careful monitoring when used with saxagliptin due to its renal elimination pathway.
- Other antihypertensive or heart failure medications: Since saxagliptin may affect heart failure patients, it should be used cautiously alongside medications like ACE inhibitors, beta-blockers, or diuretics, especially in those with compromised heart function.
Patients should inform their healthcare provider about all medications, including over-the-counter drugs and supplements, to avoid potential interactions.
The typical adult dose of saxagliptin for managing type 2 diabetes is:
- Standard dose: 5 mg once daily, taken with or without food.
- Renal impairment adjustments: For patients with moderate renal impairment (eGFR 30-50 mL/min/1.73m²), the recommended dose is 2.5 mg once daily. In patients with severe renal impairment (eGFR < 30 mL/min/1.73m²) or end-stage renal disease (ESRD) on dialysis, saxagliptin is not recommended.
Doses should be adjusted based on renal function, and patients should follow their healthcare provider’s instructions closely.
Saxagliptin is not approved for use in pediatric patients under the age of 18. It is specifically indicated for the treatment of type 2 diabetes in adults. There is limited data on the safety and efficacy of saxagliptin in children, so it should not be used in this population unless directed by a healthcare provider based on specific needs.
Saxagliptin is primarily excreted by the kidneys, so dose adjustments are necessary for patients with renal impairment:
- Mild renal impairment (eGFR 50-70 mL/min/1.73m²): No dose adjustment is necessary.
- Moderate renal impairment (eGFR 30-50 mL/min/1.73m²): The dose should be reduced to 2.5 mg once daily.
- Severe renal impairment (eGFR < 30 mL/min/1.73m²) or dialysis: Saxagliptin is contraindicated in patients with severe renal impairment or those on dialysis.
Patients with renal impairment should be monitored regularly to ensure proper dosing and avoid potential complications.
Not available in a medicine form yet